Variability in Ejection Fraction Measured By Echocardiography, Gated Single-Photon Emission Computed Tomography, and Cardiac Magnetic Resonance in Patients With Coronary Artery Disease and Left Ventricular Dysfunction by Pellikka, P. A. et al.
Touro Scholar 
NYMC Faculty Publications Faculty 
8-1-2018 
Variability in Ejection Fraction Measured By Echocardiography, 
Gated Single-Photon Emission Computed Tomography, and 
Cardiac Magnetic Resonance in Patients With Coronary Artery 
Disease and Left Ventricular Dysfunction 
P. A. Pellikka 
Lilin She 
T. A. Holly 
G. Lin 
P. Varadarajan 
See next page for additional authors 
Follow this and additional works at: https://touroscholar.touro.edu/nymc_fac_pubs 
 Part of the Medicine and Health Sciences Commons 
Recommended Citation 
Pellikka, P., She, L., Holly, T., Lin, G., Varadarajan, P., Panza, J., & Oh, J. (2018). Variability in Ejection 
Fraction Measured By Echocardiography, Gated Single-Photon Emission Computed Tomography, and 
Cardiac Magnetic Resonance in Patients With Coronary Artery Disease and Left Ventricular Dysfunction. 
JAMA Network Open, 1 (4), e181456. https://doi.org/10.1001/jamanetworkopen.2018.1456 
This Article is brought to you for free and open access by the Faculty at Touro Scholar. It has been accepted for 
inclusion in NYMC Faculty Publications by an authorized administrator of Touro Scholar. For more information, 
please contact touro.scholar@touro.edu. 
Authors 
P. A. Pellikka, Lilin She, T. A. Holly, G. Lin, P. Varadarajan, Julio Panza, and J. K. Oh 
This article is available at Touro Scholar: https://touroscholar.touro.edu/nymc_fac_pubs/1547 
Original Investigation | Cardiology
Variability in Ejection Fraction Measured By Echocardiography,
Gated Single-Photon Emission Computed Tomography,
and Cardiac Magnetic Resonance in Patients With
Coronary Artery Disease and Left Ventricular Dysfunction
Patricia A. Pellikka, MD; Lilin She, PhD; Thomas A. Holly, MD; Grace Lin, MD; Padmini Varadarajan, MD; Ramdas G. Pai, MD; Robert O. Bonow, MD, MS;
Gerald M. Pohost, MD; Julio A. Panza, MD; Daniel S. Berman, MD; David L. Prior, MBBS, PhD; Federico M. Asch, MD; Salvador Borges-Neto, MD; Paul Grayburn, MD;
Hussein R. Al-Khalidi, PhD; Karol Miszalski-Jamka, MD, PhD; Patrice Desvigne-Nickens, MD; Kerry L. Lee, PhD; Eric J. Velazquez, MD; Jae K. Oh, MD
Abstract
IMPORTANCE Clinical decisions are frequently based on measurement of left ventricular ejection
fraction (LVEF). Limited information exists regarding inconsistencies in LVEF measurements when
determined by various imaging modalities and the potential impact of such variability.
OBJECTIVE To determine the intermodality variability of LVEF measured by echocardiography,
gated single-photon emission computed tomography (SPECT), and cardiovascular magnetic
resonance (CMR) in patients with left ventricular dysfunction.
DESIGN, SETTING, AND PARTICIPANTS International multicenter diagnostic study with LVEF
imaging performed at 127 clinical sites in 26 countries from July 24, 2002, to May 5, 2007, and
measured by core laboratories. Secondary study of clinical diagnostic measurements of LVEF in the
Surgical Treatment for Ischemic Heart Failure (STICH), a randomized trial to identify the optimal
treatment strategy for patients with LVEF of 35% or less and coronary artery disease. Data analysis
was conducted from March 19, 2016, to May 29, 2018.
MAIN OUTCOMES AND MEASURES At baseline, most patients had an echocardiogram and subsets
of patients underwent SPECT and/or CMR. Left ventricular ejection fraction was measured by a core
laboratory for each modality independent of the results of other modalities, and measurements were
compared among imaging methods using correlation, Bland-Altman plots, and coverage probability
methods. Association of LVEF by each method and death was assessed.
RESULTS A total of 2032 patients (mean [SD] age, 60.9 [9.6] years; 1759 [86.6%] male) with
baseline LVEF data were included. Correlation of LVEF between modalities was r = 0.601 (for biplane
echocardiography and SPECT [n = 385]), r = 0.493 (for biplane echocardiography and CMR
[n = 204]), and r = 0.660 (for CMR and SPECT [n = 134]). Bland-Altman plots showed only moderate
agreement in LVEF measurements from all 3 core laboratories with no substantial overestimation or
underestimation of LVEF by any modality. The percentage of observations that fell within a range of
5% ranged from 43% to 54% between different imaging modalities.
CONCLUSIONS AND RELEVANCE In this international multicenter study of patients with coronary
artery disease and reduced LVEF, there was substantial variation between modalities in LVEF




Question What is the variability in left
ventricular ejection fraction (LVEF) as
measured by different cardiac imaging
modalities?
Findings In this multicenter diagnostic
study of 2032 patients with coronary
artery disease and LVEF of 35% or less
with imaging interpreted by core
laboratories, correlation of LVEF
between modalities ranged from
r = 0.493 (for biplane echocardiography
and cardiovascular magnetic resonance)
to r = 0.660 (for cardiovascular
magnetic resonance and gated single-
photon emission computed
tomography). There was no systematic
overestimation or underestimation of
LVEF for any modality.
Meaning There is substantial variability
in LVEF assessment between modalities,
which should be considered in trial
design and clinical management.
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Introduction
Feasible, accurate, and reproducible assessment of left ventricular ejection fraction (LVEF) is an
important objective of noninvasive cardiac imaging. Whether LVEF is preserved or reduced currently
forms the basis for the classification of patients with heart failure. Additionally, LVEF is an important
predictor of prognosis in patients with myocardial infarction,1-3 heart failure,4-6 and valve disease.7
Moreover, current practice guidelines use LVEF thresholds for decision making in different clinical
scenarios, such as the recommendation regarding device implantation or pharmacologic therapy in
patients with heart failure8,9 and the recommendation for valve replacement in patients with severe
valvular heart disease.10 Left ventricular ejection fraction is also a common enrollment criterion
and/or end point for clinical trials.11
Left ventricular ejection fraction can be determined by using multiple noninvasive imaging
modalities, including echocardiography, cardiac magnetic resonance (CMR) imaging, and gated
single-photon emission computed tomography (SPECT) imaging. All of these methods are routinely
used for clinical decision making as well as research study enrollment. However, few data exist
regarding the agreement between LVEF determined by these different methods. Prior studies have
been limited by small numbers of participants, sometimes including only healthy volunteers, with
imaging performed by a single center, and have compared only 2 imaging modalities.12-14 As LVEF cut
points are often the basis for clinical management decisions and trial eligibility, the implications of
variability are substantial.
The Surgical Treatment for Ischemic Heart Failure (STICH) was an international multicenter trial
aimed to compare coronary artery bypass grafting (CABG) and medical therapy for patients with
heart failure, coronary artery disease (CAD), and left ventricular (LV) systolic dysfunction defined as
LVEF of 35% or less.15,16 In this trial, any of 3 diagnostic methods (echocardiography, gated SPECT
imaging, or CMR) could be used by a local clinical site to measure LVEF in order to determine a
patient’s trial eligibility. All patients enrolled in the STICH trial were required to have a baseline
determination of LVEF, and a subset of patients underwent this determination by multiple
modalities, including echocardiography, gated SPECT imaging, and/or CMR. All LVEF data obtained
by echocardiography, CMR, and SPECT were measured by respective core laboratories. Therefore,
the STICH trial provides a unique opportunity to correlate core laboratory assessment of LVEF data
between different modalities.
We conducted this study to determine the variability among imaging modalities and among
different echocardiographic methods for assessing LVEF in patients with reduced LV systolic
function, and to compare the association between these measurements and subsequent mortality in
patients with ischemic cardiomyopathy.
Methods
Patients
A total of 2136 patients with LVEF of 35% or less were enrolled in the STICH trial.16 All patients
provided written informed consent, as approved by the local institutional review board. Patients
were enrolled at 127 clinical sites in 26 countries from July 24, 2002, to May 5, 2007; all had CAD
amenable to CABG. Each of the 127 enrolling sites had to obtain institutional review board approval
for STICH. We followed the Standards for Reporting of Diagnostic Accuracy (STARD) reporting guideline.
A manual of operation for each modality was produced by the core laboratory for that modality to
standardize imaging technique. Each site was required to submit 1 to 3 studies that fulfilled imaging
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requirements before enrollment. When studies did not meet these requirements, additional studies
were requested until requirements were met. Patients with baseline imaging data received by the core
laboratories for 1 or more imaging modalities were considered for inclusion. Patients with LVEF
measured 90 days or more from study randomization or with study quality deemed by the core
laboratory as being unusable for measurement were excluded. Determination of LVEF was performed
by a separate core laboratory for each modality, independent of clinical information, treatment
assignment, and data from other modalities.17 Each core laboratory provided oversight of quality control
and assessed the quality of each study as excellent, good, fair, borderline, or unusable. Left ventricular
end-systolic volume for each modality was indexed for body surface area.
Calculation of LVEF
Left ventricular ejection fraction was determined from LV end-diastolic volume and end-systolic
volume using the following standard formula:
LVEF = [(end-diastolic volume) – (end-systolic volume)]/end-diastolic volume
Imaging
Echocardiography was performed at most sites for patient enrollment. Determination of LVEF was
attempted according to the recommendations of the American Society of Echocardiography18 using
the Simpson method.17 Measurements were averaged over 3 cardiac cycles for patients in sinus
rhythm, and 3 to 5 cardiac cycles for those in atrial fibrillation. If 2 apical views were not available for
LV volume measurement, only 1 apical view (single-plane Simpson measurement) was used for
determination of LVEF. For Simpson measurements, the LV endocardial border was traced
contiguously from one side of the mitral annulus to the other side excluding the papillary muscles and
trabeculations. Left ventricular ejection fraction was also estimated visually in most patients and
when the definition of the LV endocardial border was not satisfactory from any of the apical views,
visual estimate was the only echocardiographic determination of LVEF.19
Gated myocardial perfusion SPECT imaging, predominantly using sestamibi, was performed at
clinical sites using a standard protocol. The gated raw projections were reconstructed by the
radionuclide core laboratory using automatic software (AutoSPECT). When appropriate, an algorithm
was applied to correct for motion. Resting studies accounted for 82% of measurements of LVEF; the
remainder was obtained from poststress studies. Gated short-axis images were reviewed by a core
laboratory technologist to optimize the accuracy of automatically determined LV contours, which
were measured in end-systole and end-diastole. Manual adjustment addressed incorrect valve plane
placement or contour deviations because of extracardiac radioactivity. Gated SPECT images were
analyzed for LVEF by the radionuclide core laboratory using quantitative gated SPECT (QGS)
software.20
Cardiac magnetic resonance imaging was performed by clinical sites that had the required CMR
platform and software.17,21 A minimum of 2 data sets of short- and long-axis views were required to
allow the core laboratory to select images of the highest quality. All gated data were displayed and
reviewed by CMR core laboratory expert technologists to verify that LV boundaries were accurately
demarcated. Short-axis images allowed determination of LVEF, using software developed by the
CMR core laboratory at the University of Southern California (USC Cardio) and based on the Simpson
method. Papillary muscles and trabeculations were considered to be part of the LV cavity. All short-
axis data were reviewed by a technologist and adjusted manually, if necessary, to optimize accuracy
of LV contour borders.
Statistical Analysis
In this secondary study of the STICH trial, agreement of the core laboratory determinations of LVEF
between modalities were assessed using 5 indices of variability: mean signed difference, mean
absolute difference, Pearson correlation coefficient, Bland-Altman plots in which the mean of 2
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measurements was plotted against the difference,22 and coverage probability.23 For determining
LVEF by echocardiography, 3 methods (biplane, single plane, and visual estimation) were included in
this comparison. For the coverage probability analysis, which is an assessment of the proportion of
participants where a prespecified level of agreement is present, agreement was assumed to be
present if the LVEF measures being compared were within 5% of each other. Because LVEF measures
with SPECT performed after stress could be influenced by ischemia or stunning, Bland-Altman plots
were repeated after exclusion of the 18% with SPECT LVEF assessed following stress. To assess the
impact of nonsimultaneous imaging, the number of days between performances of various
modalities was considered. Finally, the prognostic effect of the different measures of LVEF for
association with all-cause mortality was assessed using Cox regression models. In each case, the
relationship of LVEF with mortality was modeled using restricted cubic spline functions.24 The
relative risk of every 5% LVEF increment, expressed as hazard ratio and 95% confidence interval, was
also calculated using the Cox model. The longest available follow-up information was used for each
patient.16,25 This was a 2-sided test with a P value less than .05 required for significance.
Results
Clinical Characteristics
The population included 2032 patients (95.1%) (mean [SD] age, 60.9 [9.6] years; 1759 [86.6%] male)
of the 2136 patients in the STICH trial who had LVEF assessed by at least 1 imaging modality. A
baseline echocardiographic assessment of LVEF was received by the core laboratory in 1978 patients.
Of these, 30 (1.5%) were excluded (imaging was performed >90 days before or after randomization
in 24 cases and images were unusable in 6 cases). The remaining 1948 patients constitute the
population studied with echocardiography. Biplane Simpson method of determining LVEF was
performed in 897 (46%) of the 1948 patients. Only 3 patients (<1%) received echo contrast. Gated
SPECT images for assessment of LVEF were received by the core laboratory in 790 patients. Of these,
16 (2.0%) were excluded (imaging was performed >90 days before or after randomization in 14 cases
and images were unusable in 2 cases). The remaining 774 patients constitute the population studied
with SPECT. Cardiac magnetic resonance assessment of LVEF was performed and received by the
core laboratory in 425 patients. Of these, 7 (1.6%) were excluded (imaging was performed >90 days
before or after randomization in 6 cases and 1 patient with out-of-range LVEF measurement that
could not be confirmed by the CMR core laboratory). The remaining 417 patients constitute the
population studied with CMR. Although most patients had echocardiography, the population
included 84 patients who had only gated SPECT or CMR. Thus, 1107 (57%) of the 1948 patients with
echocardiographic determination of LVEF also had LVEF determined by a second modality.
Characteristics of the patients who were evaluable are shown in Table 1. Patients with better-quality
echocardiographic images were more likely to undergo imaging with SPECT or CMR. For those with
excellent echocardiographic image quality, 42.3% had SPECT (42.5% were good, 35.6% were fair,
and 29.7% were borderline; P < .001). For those with excellent echocardiographic image quality,
36.6% had CMR (21.1% were good, 18.2% were fair, and 15.6% were borderline; P < .001). Compared
with those who had only imaging by echocardiography, patients who also had imaging by SPECT or
CMR more often had prior myocardial infarction (79.9% vs 83.9%; P = .02), prior percutaneous
coronary revascularization (9.9% vs 21.0%; P < .001), greater anterior akinesia or dyskinesia (45.3
[50.5%] vs 48.4 [26.7%]; P < .001), and lower New York Heart Association heart failure class (class I
or II in 58% vs 61.6%; P < .001). Left ventricular ejection fraction was measured by all 3 modalities
in 127 patients; these patients compared with those with LVEF measured by 1 or 2 modalities more
often had prior myocardial infarction (93.7% vs 80.9%; P < .001), prior percutaneous coronary
revascularization (34.6% vs 14.1%; P < .001), greater anterior akinesia or dyskinesia (57.5 [13.1%] vs
46.0 [40.3%]; P < .001), and lower New York Heart Association heart failure class (class I or II in
68.5% vs 56.7%; P = .02).
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Imaging
The median time interval between echocardiography and SPECT was 3.0 days (interquartile range,
1.0-9.0 days); between echocardiography and CMR was 2.0 days (interquartile range, 1.0-6.0 days);
and between SPECT and CMR was 1.0 days (interquartile range, 1.0-5.0 days). All patients qualified
for participation in the study based on LVEF of 35% or less as assessed by the recruiting site. Thus, in
some patients, an alternative modality of determination of LVEF yielded a result of 35% or greater.
The mean (SD) for the LVEF by the core laboratories for each modality and for the various
echocardiographic methods and the numbers and percentages with LVEF of 35% or less for each
modality are shown in Table 2.













Age, mean (SD), y 60.9 (9.5) 61.2 (9.4) 61.0 (9.6)
Male 1687 (86.6) 667 (86.2) 359 (86.1)
BMI, mean (SD) 27.4 (4.6) 27.6 (4.4) 27.4 (4.5)
Hyperlipidemia 1271 (65.4) 515 (66.8) 300 (72.6)
Hypertension 1165 (59.8) 443 (57.2) 241 (57.8)
Current smoker 408 (21.0) 141 (18.2) 100 (24.0)
Diabetes 712 (36.6) 284 (36.7) 151 (36.2)
Peripheral vascular disease 292 (15.0) 122 (15.8) 51 (12.2)
Chronic renal insufficiency 152 (7.8) 60 (7.8) 26 (6.2)
Stroke 133 (6.8) 57 (7.4) 22 (5.3)
Myocardial infarction 1595 (81.9) 642 (82.9) 364 (87.3)
Previous CABG 56 (2.9) 18 (2.3) 10 (2.4)
Previous PCI 301 (15.5) 160 (20.7) 100 (24.0)
Atrial flutter or fibrillation 237 (12.2) 94 (12.1) 47 (11.3)
Current NYHA heart failure class
I 200 (10.3) 80 (10.3) 35 (8.4)
II 915 (47.0) 429 (55.4) 201 (48.2)
III 757 (38.9) 240 (31.0) 156 (37.4)
IV 76 (3.9) 25 (3.2) 25 (6.0)
Anterior akinesia or dyskinesia,
mean (SD), %
47.0 (39.2) 46.3 (29.0) 56.0 (14.6)
Study quality
Excellent 71 (3.6) 250 (32.3) 334 (80.3)
Good 791 (40.6) 380 (49.1) 66 (15.9)
Fair 578 (29.7) 134 (17.3) 13 (3.1)
Borderline 508 (26.1) 10 (1.3) 3 (0.7)
Abbreviations: BMI, body mass index (calculated as
weight in kilograms divided by height in meters
squared); CABG, coronary artery bypass grafting; CMR,
cardiovascular magnetic resonance; EF, ejection
fraction; NYHA, New York Heart Association; PCI,
percutaneous coronary intervention; SPECT, single-
photon emission computed tomography.
a Some patients have left ventricular ejection fraction
from more than 1 core laboratory.
b Continuous variables are presented as mean (SD)
and categorical variables are presented as No. (%).










Echocardiographic EF 1948 (95.9) 29.0 (8.2) 1555 (79.8)
Echocardiographic biplane EF 897 (44.1) 28.7 (8.2) 709 (79.0)
Echocardiographic single-plane EF 725 (35.7) 29.2 (8.6) 552 (76.1)
Echocardiographic visual EF 1941 (95.5) 28.5 (7.8) 1679 (86.5)
SPECT EF 774 (38.1) 26.8 (8.3) 648 (83.7)
CMR EF 417 (20.5) 27.2 (10.8) 328 (78.7)
Abbreviations: CMR, cardiovascular magnetic
resonance; EF, ejection fraction; LVEF, left ventricular
ejection fraction; SPECT, single-photon emission
computed tomography.
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Comparison of Imaging Modalities
Among 1948 patients who had LVEF assessed by echocardiography, 1437 (73.8%) of them had both
visual estimate and quantitative LVEF. The mean absolute differences between LVEF as determined
by quantitative vs visual echocardiographic methods were all less than 5% (mean absolute difference
2.7% for biplane and visual, 3.0% for single plane and visual, and 2.9% for biplane and single plane).
The mean absolute differences of LVEF by echocardiography and by other modalities were all greater
than 5% but were lowest when biplane echocardiography, rather than other echocardiographic
methods, was used (data not shown). Mean absolute difference of LVEF between modalities was
5.9% for biplane echocardiography and SPECT (n = 385), 7.3% for CMR and biplane
echocardiography (n = 204), and 5.9% for CMR and SPECT (n = 134). The variability measurements
were similar in women and men (data not shown). When only data for studies performed within 3
days were considered, results were similar: mean absolute difference 5.8% for biplane
echocardiography and SPECT (n = 213), 7.2% for CMR and biplane echocardiography (n = 126), and
5.9% for CMR and SPECT (n = 84). Even when only data for studies performed the same day were
considered, results were similar: mean absolute difference 5.2% for biplane echocardiography and
SPECT (n = 68 ), 8.6% for CMR and biplane echocardiography (n = 33), and 4.1% for CMR and SPECT
(n = 10). When only data for studies rated as having excellent or good quality were included, mean
absolute differences were again similar: 5.6% for biplane echocardiography and SPECT (n = 317),
7.3% for CMR and biplane echocardiography (n = 184), and 5.7% for CMR and SPECT (n = 116). For
the 127 patients in whom LVEF was measured by all 3 modalities, mean absolute difference between
modalities was 6.0% for echocardiography and SPECT, 6.8% for CMR and echocardiography, and
5.9% for CMR and SPECT.
Bland-Altman comparisons between modalities for determining LVEF are shown in the Figure.
Limits of agreement between modalities were broad, ranging from 28.27% to 35.31%. Bland-
Altman comparison with SPECT repeated after exclusion of LVEF assessed following stress with
SPECT were similar (eFigure in the Supplement). The mean signed difference between LVEF
measured by biplane and single-plane echocardiography was closest to 0, indicating no substantial
overestimation or underestimation of LVEF by either echocardiographic method. The mean signed
differences for LVEF between modalities were larger with wider 95% confidence intervals.
Correlations between LVEF as determined by quantitative vs visual echocardiographic methods
(r = 0.898 for biplane vs visual, r = 0.876 for single plane vs visual, r = 0.874 for biplane and single
plane) were higher than the correlations of LVEF assessed between different modalities (r = 0.601
for biplane echocardiography and SPECT, r = 0.660 for CMR and SPECT, and r = 0.493 for CMR and
biplane echocardiography).
Left ventricular ejection fraction measurements were within 5% in 54.0% for biplane
echocardiography and SPECT, 48.5% for SPECT and CMR, and 43.1% for biplane echocardiography
and CMR. Using CMR as the standard and comparing it with SPECT and echocardiography as to
whether there was intermodality agreement for LVEF greater than 35% is shown in Table 3. The
results of the 4 variability indices comparing LVEF and end-systolic volume index for the 3 modalities
are summarized in Table 4.
Prognostic Impact of LVEF According to Modality
Among the 2032 patients who had LVEF assessment, follow-up was available in all, although it was
abbreviated in 32 cases (1.6%). The prognostic effect of LVEF by modality and outcome was
assessed. During a mean (SD) follow-up of 5.0 (3.3) years, there were 966 deaths. Among 1948
patients who had echocardiographic LVEF assessment, the prognostic effect of LVEF by method
(biplane, single plane, or visual estimation) was examined. Left ventricular ejection fractions
measured by different methods were all statistically significant in terms of their prognostic value with
respect to all-cause mortality. The HR (0.83-0.89) and the associated 95% confidence intervals for
every 5% LVEF increment were all similar and below 1.00. This indicates increased LVEF was
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associated with decreased mortality risk, regardless which modality for determining LVEF was used
(eTable in the Supplement).
Discussion
Left ventricular ejection fraction refers to the fraction of LV end-diastolic volume ejected during
systole. It is the most widely used measure of assessment for LV systolic function and is familiar to
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Plots are compared for biplane Simpson method and visual estimation for
echocardiography (A), biplane Simpson method by echocardiography and gated single-
photon emission computed tomography (SPECT) (B), biplane Simpson method by
echocardiography and cardiovascular magnetic resonance (CMR) (C), and gated SPECT
and CMR (D).




No. (%) of Patients
Both EF ≤35% Both EF >35% 2 EFs Agreed
CMR EF ≤35% and
Comparison EF >35%
CMR EF >35% and
Comparison EF ≤35% 2 EFs Disagreed
Echocardiographic EF 377 243 (64.5) 37 (9.8) 280 (74.3) 54 (14.3) 43 (11.4) 97 (25.7)
Echocardiographic
biplane EF
204 134 (65.7) 18 (8.8) 152 (74.5) 34 (16.7) 18 (8.8) 52 (25.5)
Echocardiographic
single-plane EF
130 80 (61.5) 17 (13.1) 97 (74.6) 18 (13.9) 15 (11.5) 33 (25.4)
Echocardiographic
visual EF
375 271 (72.3) 25 (6.7) 296 (78.9) 24 (6.4) 55 (14.7) 79 (21.1)
SPECT EF 134 90 (67.1) 19 (14.2) 109 (81.3) 10 (7.5) 15 (11.2) 25 (18.7)
Abbreviations: CMR, cardiovascular magnetic resonance; EF, ejection fraction; LVEF, left ventricular ejection fraction; SPECT, single-photon emission computed tomography.
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patients and clinicians. This is the first study to compare echocardiographic, CMR, and SPECT
methods for determination of LVEF in a large, international, multicenter cohort of patients included
in a clinical trial with extensive follow-up. In this population with LV dysfunction and CAD, we found
that there was substantial variation among modalities for determination of LVEF even though these
measures were made by specialized core laboratories, each of which followed specific plans for
image analysis and measurements.19,26 Acquisition of data at 127 sites worldwide may have
contributed to this variability. Moreover, variation was not predictable; there was no substantial
overestimation or underestimation of LVEF by any modality relative to another.
Surprisingly, few studies have assessed the differences in LVEF as measured by different
imaging modalities.12-14,27 Previous studies were predominantly single center, most with fewer than
100 participants, and most recent studies have focused on 3-dimensional or contrast
echocardiography. These newer techniques were associated with improved reproducibility and
agreement with CMR.28,29
Correlations between various methods of determination of LVEF by a single modality,
echocardiography, were similar and better (r = 0.898 for biplane and visual estimation; r = 0.874 for
single plane and biplane; and r = 0.876 for single plane and visual) than were correlations between
different modalities, which ranged from r = 0.493 (for biplane echocardiography and CMR) to
r = 0.660 (for CMR and SPECT). The good correlation between visual estimation and measurement
of echocardiographic images is of interest; however, it should be noted that visual estimates were
made by echocardiographic core laboratory staff, who had advanced training and extensive
experience. Results might be worse with less experienced reviewers. Although the 3
echocardiographic methods assessed were well correlated, LVEF by biplane method of disks should
be used when feasible as it correlated best with LVEF by other modalities.
Bland-Altman analysis showed no substantial overestimation or underestimation of LVEF by
different modalities. Biplane quantitation with echocardiography averaged only 2.5% higher than
CMR and 2.2% higher than gated SPECT, and SPECT was 0.8% higher than CMR. Limits of agreement
were broad. Variability between modalities for measures of LV end-systolic volume index were
also broad.
Variation of LVEF within 5% between modalities might be considered clinically acceptable.
However, the percentage of observations that fell within a range of 5% ranged from 43% to 54%
between different imaging modalities. Discordance between modalities as to whether LVEF was
greater than 35% was present in about 20% to 25% of cases. Had core laboratory determination of
LVEF been used for enrollment in the STICH trial, which required LVEF of 35% or less, many of these
patients would have been ineligible.
Table 4. Variability Indices for LVEF and ESVI Measures Between Modalities
Pairwise Comparison of Core Laboratory
LVEF or ESVI Measures Mean Signed Difference Mean Absolute Difference Correlation Coefficient
Bland-Altman Limit
of Agreement Rangea Coverage Probabilityb
Echocardiographic biplane EF vs SPECT EF,
% (n = 385)
2.2 5.9 0.601 28.27 0.540
SPECT EF vs CMR EF, % (n = 134) 0.8 5.9 0.660 30.36 0.485
Echocardiographic biplane EF vs CMR EF,
% (n = 204)
2.5 7.3 0.493 35.31 0.431
Echocardiographic biplane ESVI vs SPECT
ESVI, mL/m2 (n = 386)
−12.8 20.8 0.821 97.92 0.332
SPECT ESVI vs CMR ESVI, mL/m2 (n = 134) 11.0 17.9 0.821 83.04 0.358
Echocardiographic biplane ESVI vs CMR
ESVI, mL/m2 (n = 204)
−3.8 18.8 0.786 26.67 0.353
Abbreviations: CMR, cardiovascular magnetic resonance; EF, ejection fraction; ESVI,
end-systolic volume index; LVEF, left ventricular ejection fraction; SPECT, single-photon
emission computed tomography.
a Bland-Altman limit of agreement range is between 1.96 standard deviation of the
differences between the 2 imaging modalities. Approximately 95% of the differences
are expected to fall within this range.
b Coverage probability is the proportion of participants who fall within the prespecified
acceptable paired absolute difference. For LVEF, the prespecified acceptable paired
absolute difference was 5% or less. For ESVI, the prespecified acceptable paired
absolute difference was 10 mL/m2.
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The decision to perform SPECT or CMR was made by the clinical site. Patients with greater
akinesia or dyskinesia were more likely to undergo CMR. Geometric abnormalities of the left ventricle
may have contributed to the discordance between modalities for determining LVEF. In particular,
echocardiographic biplane and single-plane methods rely on geometric assumptions, whereas SPECT
and CMR methods assess the LV tomographically, without these assumptions. This may have
contributed to the poor concordance of echocardiography and the other methods. Had patients with
worse echocardiographic images been more likely to be referred for additional imaging, this might
have accounted for a poorer correlation between echocardiography and other modalities. However,
patients with better echocardiographic image quality more often underwent performance of
additional imaging with SPECT or CMR.
The prognostic effect of LVEF by different echocardiographic methods and between modalities
was also assessed. Although LVEF measurements from different methods and modalities have
significant variations, analyses in this study indicate LVEF was strongly prognostic of all-cause
mortality in the univariable Cox regression models no matter which method or modality was used.
Because LVEF was determined by different modalities for different patients, direct comparison of the
prognostic effect for LVEF by various modalities was not possible.
Limitations
No gold standard exists for determining LVEF; agreement between modalities was assessed by
various statistical methods. All patients had reduced LVEF. Correlations may have been better had
the population included patients with a full spectrum of values. A broader spectrum of values of LVEF
would be expected to be encountered in most clinical situations. Despite recommendations that
LVEF be determined using biplane Simpson method, this was possible in only 897 of patients with
echocardiography (46%). Ultrasonography contrast agents, recommended for use when imaging is
suboptimal,30 have been shown to improve correlation with CMR but were used in only 3
patients.14,31 Three-dimensional echocardiographic imaging is increasingly being used for
determination of LVEF and may improve the agreement between echocardiography and other
methods, but it is not available on all ultrasonography systems and was not used in this study.32
Similarly, technology for SPECT and CMR also continues to be refined; such improvements may
reduce differences between modalities. The SPECT LVEF measurements obtained from poststress
studies may have been lower than rest studies in patients with extensive ischemia. However, even
after exclusion of data in which SPECT LVEF was assessed following stress, results were similar with
wide limits of agreement. Only a subset of patients was referred for SPECT and CMR; decisions about
referral were made at local sites. Only 57% of patients who underwent echocardiography had LVEF
determined by a second modality. Only 38% of patients included in the analysis had LVEF
determined by SPECT, and only 20.5% of patients included in the analysis had LVEF determined by
CMR. Since not all patients included in the STICH trial had LVEF determined by 2 different modalities,
there may have been selection bias in choosing patients who had LVEF determined by a second
imaging modality.
Assessments by different modalities were not simultaneous, and intervening medical therapy
or ischemia may have affected LVEF. Left ventricular ejection fraction can be affected by changes in
preload, afterload, and LV remodeling.33 Data regarding changes in pharmacologic therapy or blood
pressure between tests were not available. The median time interval between studies was 3 days
between echocardiography and SPECT studies, 2 days between echocardiography and CMR studies,
and 1 day between SPECT and CMR studies. Correlations were not consistently improved when tests
were performed within 3 days or on the same day. Reproducibility of LVEF determination may be
affected by image quality,34 but correlations were not improved when only images of good or
excellent quality were included.
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Conclusions
Although LVEF is a widely reported measurement and is the cornerstone of many treatment
decisions, there is substantial variability in its measurement using different modalities, even when
assessed by core laboratories. In this international study in which LVEF imaging was performed at 127
clinical sites using up to 3 widely used imaging modalities and LVEF was independently measured by
core laboratories according to standard protocols, the variability in LVEF measurement exceeded 5%
in about half of the patients. Variability was less for different methods of determining LVEF when a
single imaging modality (echocardiography, in this case) was used. Longitudinal assessments of a
given patient may best be accomplished using a single imaging modality.
The diagnostic and prognostic importance of LVEF as well documented in numerous studies is
not disputed. Left ventricular ejection fraction by each modality was associated with mortality.
However, variability in LVEF assessment by different imaging modalities should be considered in trial
design and clinical management. Considering this variability, cut points in LVEF should not be the
sole basis for decision making.
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